In a report released today, Brian Tanquilut from Jefferies maintained a Buy rating on CVS Health (CVS – Research Report), with a price target of $69.00. The company’s shares closed
In a report released today, Brian Tanquilut from Jefferies maintained a Buy rating on CVS Health (CVS – Research Report), with a price target of $69.00. The company’s shares closed
CVS Health (CVS – Research Report), the Healthcare sector company, was revisited by a Wall Street analyst yesterday. Analyst Erin Wright from Morgan Stanley maintained a Buy rating on the
לאחר סקירת רוב הדוחות הכספיים, הפירמה מעדכנת את המודלים והניתוחים הכספיים המפורטים שלה עבור כל ארגון ניהול טיפול (MCO) בעל שווי שוק גדול. Wells Fargo אינם כוללים שינויים הקשורים לבחירות
Wells Fargo analyst Stephen Baxter lowered the firm’s price target on CVS Health (CVS) to $60 from $61 and keeps an Equal Weight rating on the shares. Following the bulk
Wells Fargo analyst Steve Baxter maintained a Hold rating on CVS Health (CVS – Research Report) yesterday and set a price target of $60.00. The company’s shares closed last Friday